Endocrine function in HIV-infected women.
Infection with the human immunodeficiency virus (HIV) results in a chronic systemic illness with multi-organ involvement, severe immunosuppression and profound cachexia. It has had a major impact on women's health. Endocrine abnormalities may contribute to the clinical presentation and therefore appropriate treatment would theoretically improve the patient's condition. This pilot study was undertaken to assess the endocrine status in a group of HIV seropositive women with the view to developing recommendations for future investigations. Thirteen women were recruited from a clinic for HIV-infected patients. All women had a comprehensive general and gynecological examination. Basal endocrine status was assessed and combined pituitary testing with gonadotropin-releasing hormone, thyrotropin-releasing hormone, growth hormone-releasing hormone and corticotropin-releasing hormone was performed. None of the participating women presented with gynecological complaints or had symptoms suggestive of an endocrinopathy. On questioning, seven women complained of menstrual abnormalities. Three had a body mass index of less than 20 kg/m2. Genital tract infections were common. Endocrine assessment demonstrated abnormalities of the pituitary-adrenal, pituitary-thyroid and pituitary-ovarian axes in seven women. One woman had panhypopituitarism. In six of the seven affected women CD4 counts were below 200 cells/mm3. Alterations in endocrine function were observed in seven of the women tested. While routine endocrine testing may not be indicated in all HIV-seropositive women, we should be aware of possible subtle presentations of endocrine abnormalities which may require treatment, especially in stress situations.
Hinz
S
S
Department of Obstetrics and Gynecology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
McCormack
D
D
van der Spuy
Z M
ZM
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000503:physiopathology; D000311:Adrenal Glands / Q000503:physiopathology; D000328:Adult; D015992:Body Mass Index; D018791:CD4 Lymphocyte Count; D003346:Corticotropin-Releasing Hormone; D004702:Endocrine Glands / Q000503:physiopathology*; D005260:Female; D005831:Genital Diseases, Female / Q000150:complications; D007987:Gonadotropin-Releasing Hormone; D013007:Growth Hormone-Releasing Hormone; D015658:HIV Infections / Q000150:complications / Q000503:physiopathology*; D006679:HIV Seropositivity; D006801:Humans; D007239:Infections / Q000150:complications; D008599:Menstruation Disturbances / Q000150:complications; D010053:Ovary / Q000503:physiopathology; D010902:Pituitary Gland / Q000503:physiopathology; D013961:Thyroid Gland / Q000503:physiopathology; D013973:Thyrotropin-Releasing Hormone
D007987:Gonadotropin-Releasing Hormone; D013973:Thyrotropin-Releasing Hormone; D003346:Corticotropin-Releasing Hormone; D013007:Growth Hormone-Releasing Hormone